Sunitinib (SU) in Patients with Advanced, Progressive Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results from a Phase III Randomized Study Including Adjustment for Crossover Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Raymond, E., Niccoli, P., Castellano, D., Valle, J., Hammel, P., Raoul, J. L., Vinik, A., Bang, Y. J., Lee, S. H., Borbath, I, Lombard-Bohas, C., Metrakos, P., Smith, D. M., Chen, J., Seitz, J. S., Patyna, S., Lu, D. R., Ishak, J., Faivre, S., Ruszniewski, P.

authors

publication date

  • January 1, 2016

webpage

published in

author keyword

  • OS
  • Sutent

category

start page

  • 84

end page

  • 84

volume

  • 103